Clinical trial

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

NCT05520853

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-01-20

PhasePHASE2

Study timeline

Study start (actual)2020-01-20Date precision: day

Registry last updated2022-08-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLCunresolved

Interventions

SBRT combined with PD-1 inhibitors and thoracic hyperthermiaRADIATION

Sponsors & collaborators

First People's Hospital of Hangzhoulead sponsor

Hangzhou Cancer Hospitalcollaborator

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05520853 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.